Anish Bhatnagar - Oct 1, 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Anish Bhatnagar
Stock symbol
SLNO
Transactions as of
Oct 1, 2024
Transactions value $
-$1,069,306
Form type
4
Date filed
10/3/2024, 05:53 PM
Previous filing
Aug 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale -$958K -19.4K -2.62% $49.34 722K Oct 1, 2024 Direct F1, F2, F3
transaction SLNO Common Stock Sale -$112K -2.22K -0.31% $50.25 720K Oct 1, 2024 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
F2 This transaction was executed in multiple trades at prices ranging from $48.95 to $49.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F4 This transaction was executed in multiple trades at prices ranging from $49.95 to $50.49. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.